An artificial pancreas that could end the need for daily insulin injections by diabetics has been developed by researchers at Leicester’s De Montfort University.
The device uses a gel that liquefies as the body’s glucose levels rise, allowing insulin to flow into the body. As the insulin brings glucose levels down, the gel hardens, stopping the insulin supply.
The device, developed by Professor Joan Taylor (pictured), is expected to begin clinical trials within the next couple of years.
The device may only be suitable for type-1 diabetes, although trials will assess it for both type-1 and type-2 diabetes.